Andrew Hore

Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.

IOG increases gas rates and Microsaic Systems short of cash

A beneficiary of the new UK Biological Security Strategy

Aquis weekly movers: Coinsilium share price recovery

AIM weekly movers: Strip Tinning share buying

Non-Standard Finance shareholders set to get nothing

AIM movers: Pelatro contract success and weak advertising at Audioboom

AIM movers: Biome Technologies contract and poor flows for Falcon Oil & Gas

Esken falls despite significant break up value

AIM movers: i-nexus convertible funding and Live Company’s late accounts

Gear4Music has platform for recovery

Frasers buys stake in boohoo

AIM movers: Vertu Motors higher on Lookers bid and Capital Metals discount placing

Signs of recovery at musicMagpie

AIM movers: Litigation Capital award and Allergy Therapeutics returns from suspension

Momentum sustained at AIM asset manager

Aquis weekly movers: SulNOx Group US patent

AIM weekly movers: Sancus Lending recovery

AIM movers: Better outlook for CT Automotive and Marlowe considers disposal

Why companies left AIM in May 2023

JLEN Environmental increases NAV by 7%.

AIM movers: Eden Research flowers in Colombia and ex-dividends

Marks Electrical continues share gain

AIM movers: Aptamer Alzheimer’s test success and GCM Resources discount

AIM movers: Yourgene sells Taiwan subsidiary and Sound Energy obtains financing deal

New standard listing: Altona Rare Earths

AIM movers: Quadrise collaboration and Myanmar Investment NAV falls by two-thirds

AO World partners with Frasers Group

New standard listing: Amicorp FS

Aquis weekly movers: ABF bids for National Milk Records

AIM weekly movers: Acuity RM recovers on back of contract

Xpeng – the Tesla rival whose shares have rallied 315% in two months

23/11/2020

‘End of Austerity’ promise hashed out during PMQs

10/10/2018

Brexit: 5,000 City jobs could leave UK

10/10/2018

Advanced Oncotherapy shares soar after cancer treatment milestone

10/10/2018

Two reasons Travelodge backers can expect sleepless nights

24/07/2020